Zafgen Inc (NASDAQ:ZFGN) Sellers Rose Their Shorts By 13.18% As Of Jun 29, 2018

June 29, 2018 - By Susanne Funderburg

Zafgen, Inc. (NASDAQ:ZFGN) Corporate Logo

Change of 13.18% for Zafgen Inc (NASDAQ:ZFGN)’s shorted shares was showed. In June was issued ZFGN’s total 677,600 shorted shares by FINRA. The 598,700 previous shares are up with 13.18%. Zafgen Inc (NASDAQ:ZFGN) has 171,500 shares average volume. It’ll cost 4 days for ZFGN to recover its former position. Zafgen Inc’s shorted shares float is 3.01%.

The stock increased 3.96% or $0.38 during the last trading session, reaching $9.98.Zafgen, Inc. has 539,372 shares volume, 114.87% up from normal. ZFGN is uptrending and has moved 60.78% since June 29, 2017. ZFGN outperformed the S&P500 by 48.21%.

Zafgen, Inc., a biopharmaceutical company, focuses on the development of therapeutics for patients suffering from metabolic diseases comprising type 2 diabetes and obesity.The firm is valued at $275.08 million. The companyÂ’s lead product candidate is ZGN-1061, a fumagillin-class MetAP2 inhibitor administered by subcutaneous injection, which is in Phase 1 clinical trial and profiled for its utility in the treatment of metabolic diseases.Currently it has negative earnings.

Zafgen, Inc. (NASDAQ:ZFGN) Ratings Coverage

A total of 2 analysts rate Zafgen (NASDAQ:ZFGN) as follows: 1 “Buy”, 1 “Hold” and 0 “Sell”. Тherefore 50% are bullish. (NASDAQ:ZFGN) has 2 ratings reports on Jun 29, 2018 according to StockzIntelligence.

For more Zafgen, Inc. (NASDAQ:ZFGN) news announced briefly go to:,,, or The titles are as follows: “Zafgen: 3 Key Takeaways From ADA Abstracts” announced on June 26, 2018, “48 Biggest Movers From Yesterday” on June 29, 2018, “Benzinga’s Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut” with a publish date: June 28, 2018, “Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to …” and the last “Zafgen Announces Proposed Offering of Common Stock” with publication date: June 27, 2018.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: